DeviceTalks Podcast Network

In this episode of DeviceTalks Weekly, Host Tom Salemi talks with Preceptis Medical CEO Dave Carey about his path from MedTech sales to the corner office.

Carey shares lessons from launching disruptive technologies at Boston Scientific, Medtronic, Stryker and Pristine Surgical, including what he looks for when hiring salespeople and what it takes to change established clinical workflows. Carey also explains why his new role at Preceptis is personal. After his daughter experienced emergence delirium following anesthesia for an ear tube procedure, Carey was drawn to Hummingbird, Preceptis’ technology for moving ear tube procedures out of the OR and into the physician’s office without general anesthesia.

He explains how Preceptis is working with ENTs, pediatricians and parents to drive adoption and why changing even a five-minute procedure requires more than selling a medical device. For more information, visit https://www.hummingbirdeartubes.com 

We’ll open the episode with Newmarker’s Newsmakers featuring Mindray, Boston Scientific, Medtronic and Johnson & Johnson MedTech.

This episode is sponsored by DeviceTalks Tuesdays Connected Health Series. Register at DeviceTalks.com. 

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:01:13) - A bit of news from Tom Salemi
(00:06:18) - Medtronic hires former Recor CEO to run interventional cardiology group
(00:08:15) - Mindray looks to fill hospital ventilator gap left by Philips’ exit
(00:09:39) - Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
(00:11:15) - Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
(00:14:25) - Johnson & Johnson drops LAA assets following suspended pivotal study
(00:17:55) - Keynote Interview: Dave Carey, CEO, Preceptis Medical

In this episode, MassDevice Editor Chris Newmarker interviews Shan Jegatheeswaran, Global President, Polyphonic, Johnson & Johnson MedTech, about what’s to come after the transformation brought to the operating room by digital surgery and robotics.

Jegatheeswaran reports that a new wave of surgical intelligence could take that transformation much further by connecting devices, data, AI and clinicians across the entire perioperative pathway. Jegatheeswaran explains why the biggest challenges may no longer be technological. Interoperability, economic incentives, governance, change management and trust all have to evolve alongside AI and connected medical devices.

We’ll open the episode with this week’s Newmarker’s Newsmakers – Petal Surgical, Boston Scientific, Medtronic, Zimmer Biomet and Abbott.

This episode is sponsored by DeviceTalks West. Go to west.devicetalks.com.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:09:55) - Petal Surgical says its first-in-human incisionless surgery is coming soon and offers a first glimpse of its system
(00:12:10) - Boston Scientific could miss guidance over cybersecurity incident
(00:15:02) - Medtronic veteran joins Teleflex’s board
(00:17:14) - Zimmer Biomet lets go of former Nevro CEO amid leadership restructuring
(00:19:32) - Abbott earns FDA approval for new dual-energy ablation catheter
(00:22:46) - Shan Jegatheeswaran, Global President, Polyphonic, Johnson & Johnson MedTech

In this episode, Host Tom Salemi sits down with Eliane Schutte, CEO of Xeltis, to discuss a remarkable biomaterial designed to help the body grow its own living blood vessels. Schutte explains how the technology is being used for dialysis patients today and how it could eventually transform coronary bypass surgery, peripheral vascular care and even heart valve replacement.

In the FOMO studio, Tom speaks with Katie Grant, VP of MR at Siemens Healthineers North America, about the global helium supply and why the MRI industry is working to reduce its reliance on the increasingly precious gas. They explore how new magnet designs could make MRI systems lighter, more accessible and easier to install in new locations.

As always, we’ll open the podcast with the top stories from MassDevice in Newmarker’s Newsmakers, delivered by MassDevice Editor Chris Newmarker. This week, Chris covers Medtronic’s major investment in surgical robotics, Enovis’ acquisition of eCential Robotics, Stryker’s move to strengthen its shoulder portfolio, the rebranding of Johnson & Johnson MedTech, and job shifts at Zoll Medical.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:04:35) - Zoll Medical is closing a California facility
(00:07:33) - Stryker to acquire ZuriMed to boost shoulder offerings
(00:09:35) - Enovis to acquire eCential Robotics for €155 million, plans to bring surgical robot to market
(00:11:58) - J&J MedTech is rebranding Shockwave Medical
(00:14:06) - Medtronic invests $780M in two companies amid Street-beating Q2
(00:17:10) - FOMO – The State of Helium in MR – Katie Clark, Siemens Healthineers
(00:31:38) - Keynote Interview – Eliane Schutte, CEO, Xeltis

The best leaders do more than set a vision. They know what good looks like—and can help others build toward it.

In this episode of the Women in MedTech podcast, Host Kayleen Brown talks with Jaime LaMontagne, Chief Marketing Officer of Astrin Biosciences, about the leadership skills behind effective MedTech marketing. Jaime reflects on her 18 years at Medtronic, where she held a series of marketing and leadership roles across urology, neuromodulation, cardiac rhythm, and perfusion. She shares how that experience—along with her work at Smiths Medical and Exact Sciences—shaped her approach to communication, commercial strategy, and leading through change.

Jaime explains why marketers must practice situational leadership: adapting messages for sales teams, physicians, engineers, executives, and patients while grounding every claim in evidence. She also discusses Astrin Biosciences’ work to advance breast cancer detection for women with dense breasts, including the promise behind Certitude, Astrin’s blood-based test in development.

As she reflects on moving from large organizations to startup life, Jaime shares the episode’s defining insight: experience gives leaders a clear picture of what good looks like. The work is then to break that vision into practical steps, build the right foundation, and create momentum alongside the people who will bring it to life.

*Editors note: This interview was recorded before the Certitude Blood Test launched. Certitude is now available, visit www.certitudetest.com to learn more and follow Certitude test on Facebook or Instagram.

Thank you to MedtechWOMEN for sponsoring this episode of the DeviceTalks Women in MedTech podcast, to learn more about MedtechVISION 2026 visit https://medtechwomen.org/.

***

Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this podcast episode, Tito Porras, MD, MBA, CEO and co-founder of startup Inner Logic, shares his unusual path to MedTech entrepreneurship with Host Tom Salemi.

Dr. Porras was training to become a neurosurgeon at Johns Hopkins when he began questioning the limits of surgeon training. He realized that even better training wouldn't solve the larger problem: there aren't enough surgeons to provide the care patients need. That realization eventually led Porras to entrepreneurship and Inner Logic, which is developing intelligence and simulation infrastructure that can help develop devices with greater autonomy.

Porras explains the difference between automation and autonomy, how AI can help devices perceive and adapt to what's happening during a procedure, and why this technology could eventually expand access to surgical care. Dr. Porras also discusses Inner Logic's work with virtual patients and synthetic data, the potential for autonomy across endovascular, orthopedic and surgical applications, and why the future of autonomous surgery will likely arrive through a series of incremental steps rather than one dramatic leap.

MassDevice Editor Chris Newmarker kicks off the podcast with Newmarker's Newsmakers, covering the FDA, Haemonetics, Senseonics, Johnson & Johnson MedTech and Medtronic.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:15) - Trump nominates policy aide as next FDA commissioner
(00:09:28) - Haemonetics reconnects with CSL in US plasma collection deal
(00:13:22) - Senseonics sees activist investor take a major stake
(00:16:08) - Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software
(00:17:45) - Medtronic faces potential injunction in Applied Medical case
(00:22:26) - Keynote Interview – Tito Porras, MD, CEO and Co-Founder of Inner Logic